receive daily
reports of the
TOP PICKS
OR
your personal
stock choices
| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
|
| There are 7 registered members and 66 guests viewing the site. | Follow us on Twitter |  Rss Top Picks Feed | Rss Daily Feed |
|
| TOP PICK | 6.280 | Duncan Stewart | Likes their product AMD-3100 which harvests bone marrow cells with remarkable effect prior to chemo therapy. Lots of cash. Has more upside and less risk than the average biotech. | 2004-11-12 | |
| DON'T BUY | 4.450 | Martin Hubbes, CFA | When their cancer drug didn't meet expectations, their partner dropped out. Have a lot of cash, but there are better companies available. | 2002-03-06 | |
| BUY | 17.650 | Bruce Cooper | One of the best 2/3 junior biotechs. Working on 3 products. Good partnerships. | 2001-04-17 | |
| TOP PICK | 18.150 | Steven Misener | In phase 2 for aids, cancer drugs & phase 3 for a kidney failure drug. Big partners | 2001-01-23 | |
| TOP PICK | 22.000 | Bruce Cooper | Has partnerships with leading global pharmaceuticals. Products are now in WAIT stage. | 2000-12-08 |
